194 related articles for article (PubMed ID: 20824477)
21. Host cellular signaling induced by influenza virus.
Dai X; Zhang L; Hong T
Sci China Life Sci; 2011 Jan; 54(1):68-74. PubMed ID: 21253874
[TBL] [Abstract][Full Text] [Related]
22. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
23. Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.
Gómez-Lucía E; Rodríguez F
Drug News Perspect; 2010; 23(1):65-70. PubMed ID: 20155220
[TBL] [Abstract][Full Text] [Related]
24. Influenza virus-host interactomes as a basis for antiviral drug development.
Watanabe T; Kawaoka Y
Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
[TBL] [Abstract][Full Text] [Related]
25. Gene silencing: a therapeutic approach to combat influenza virus infections.
Khanna M; Saxena L; Rajput R; Kumar B; Prasad R
Future Microbiol; 2015; 10(1):131-40. PubMed ID: 25598342
[TBL] [Abstract][Full Text] [Related]
26. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
27. Hijacking of the host-cell response and translational control during influenza virus infection.
Kash JC; Goodman AG; Korth MJ; Katze MG
Virus Res; 2006 Jul; 119(1):111-20. PubMed ID: 16630668
[TBL] [Abstract][Full Text] [Related]
28. Use of siRNAs to prevent and treat influenza virus infection.
Ge Q; Eisen HN; Chen J
Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
[TBL] [Abstract][Full Text] [Related]
29. Towards a systems biology understanding of human health: interplay between genotype, environment and nutrition.
Desiere F
Biotechnol Annu Rev; 2004; 10():51-84. PubMed ID: 15504703
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
Tamura S; Tanimoto T; Kurata T
Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
[TBL] [Abstract][Full Text] [Related]
31. Vaccine design of hemagglutinin glycoprotein against influenza.
Chen JR; Ma C; Wong CH
Trends Biotechnol; 2011 Sep; 29(9):426-34. PubMed ID: 21640418
[TBL] [Abstract][Full Text] [Related]
32. Translational implications of inflammatory biomarkers and cytokine networks in psychoneuroimmunology.
Yan Q
Methods Mol Biol; 2012; 934():105-20. PubMed ID: 22933143
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
34. Quantitative phosphoproteomic analysis of host responses in human lung epithelial (A549) cells during influenza virus infection.
Dapat C; Saito R; Suzuki H; Horigome T
Virus Res; 2014 Jan; 179():53-63. PubMed ID: 24291252
[TBL] [Abstract][Full Text] [Related]
35. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
36. The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology.
Sherman AC; Mehta A; Dickert NW; Anderson EJ; Rouphael N
Front Cell Infect Microbiol; 2019; 9():107. PubMed ID: 31065546
[No Abstract] [Full Text] [Related]
37. Development and Effects of Influenza Antiviral Drugs.
Yin H; Jiang N; Shi W; Chi X; Liu S; Chen JL; Wang S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33557246
[TBL] [Abstract][Full Text] [Related]
38. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
Agusti A; Sobradillo P; Celli B
Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
[TBL] [Abstract][Full Text] [Related]
39. BiologicalNetworks--tools enabling the integration of multi-scale data for the host-pathogen studies.
Kozhenkov S; Sedova M; Dubinina Y; Gupta A; Ray A; Ponomarenko J; Baitaluk M
BMC Syst Biol; 2011 Jan; 5():7. PubMed ID: 21235794
[TBL] [Abstract][Full Text] [Related]
40. Influenza infection in human host: challenges in making a better influenza vaccine.
Virk RK; Gunalan V; Tambyah PA
Expert Rev Anti Infect Ther; 2016; 14(4):365-75. PubMed ID: 26885890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
